allodynia from glp 1 Understanding Allodynia: A Side Effect of GLP-1 Medications Allodynia is being reported with

"As we expand access to obesity treatments for more Americans and advance one of the most innovative obesity pipelines, we remain focused on improving outcomes, strengthening the U.S

This was predicted to stabilise the N-terminal -helix (5-18) of the peptide through formation of an intramolecular salt bridge, as observed in a crystal structure of CagriBB fused at the C-terminal end of maltose-binding protein (PDB:7BG0) 2

This process removes water under low pressure, transforming the peptide into a stable, powdered state that can withstand transport and storage without degrading

Nelson, L

IUBMB life 60 , 790797, doi: 10.1002/iub.124 (2008)